TL;DR

Accounting for biotechnology firms is different from normal small-business accounting because biotech companies often spend years on research, clinical trials, regulatory work, grants, and fundraising before generating revenue. A biotech accounting partner helps track R&D expenses, CRO invoices, grant funding, payroll, tax credits, burn rate, runway, and investor-ready financials.

Bay Forward provides specialized biotech accounting services for life sciences, pharmaceutical, medtech, and biotech companies that need accurate books, audit preparation, tax support, and financial visibility.

What Is Accounting for Biotechnology Firms?

Accounting for biotechnology firms is the process of recording, classifying, reporting, and analyzing the financial activity of biotech and life sciences companies.

Biotech accounting covers normal accounting tasks such as bookkeeping, payroll, accounts payable, financial statements, and tax preparation. It also includes industry-specific areas such as R&D cost tracking, clinical trial accounting, grant accounting, milestone revenue recognition, investor reporting, and audit preparation.

Biotechnology companies need specialized accounting because their financial activity is connected to long research cycles, scientific development, regulatory milestones, clinical testing, and investor funding.

Bay Forward explains that biotech and life sciences finance has special needs because R&D cycles are long, rules change, oversight is strict, and money management is difficult.

Why Biotechnology Firms Need Specialized Accounting

Biotechnology firms need specialized accounting because their expenses, funding, and reporting requirements are more complex than standard business operations.

A normal business may focus on sales, expenses, profit, and taxes. A biotech company often focuses on R&D spend, clinical trial costs, cash runway, grant restrictions, investor updates, and audit readiness.

The main accounting challenges for biotech firms include:

1. R&D cost classification.
2. Clinical trial accruals.
3. CRO invoice tracking.
4. Grant and non-dilutive funding reconciliation.
5. Payroll and equity compensation.
6. R&D tax credit documentation.
7. Burn rate and runway reporting.
8. Audit and due diligence preparation.
9. Investor and board reporting.
10. Revenue recognition for licensing or milestone agreements.

This is why biotech firms usually need more than basic bookkeeping.

R&D Cost Tracking for Biotechnology Companies

R&D cost tracking is one of the most important parts of biotech accounting.

Biotech R&D expenses may include scientist salaries, lab supplies, preclinical research, clinical trial costs, CRO fees, regulatory consultants, testing, research equipment, patent-related costs, and external development work.

Under U.S. GAAP, research and development costs are generally expensed as incurred, which makes correct R&D classification important for financial statements and tax planning.

A biotech accounting partner helps separate R&D costs from general administrative expenses. This gives founders, investors, and auditors a clearer view of how capital is being used.

Clinical Trial Accounting

Clinical trial accounting tracks costs connected to research studies, clinical sites, CROs, patient enrollment, investigator payments, monitoring, lab testing, and regulatory work.

Clinical trial accounting is complex because invoices may arrive before, during, or after services are performed. A company may need to record prepaid expenses, accrued expenses, milestone costs, and trial-specific budgets.

Biotech companies should track clinical trial costs by:

• Trial phase.
• Program.
• Vendor.
• CRO.
• Clinical site.
• Patient enrollment milestone.
• Contract milestone.
• Prepaid or accrued status.

Bay Forward’s biotech accounting service includes CRO invoice review, clinical site payment tracking, grant budget alignment, and milestone revenue recognition support.

Grant Accounting and Non-Dilutive Funding

Many biotechnology firms use grants, research awards, government funding, or non-dilutive financing.

Grant accounting matters because funds may be restricted to specific research activities, budgets, timelines, or reporting requirements. A biotech company must show how grant funds were received, used, deferred, or recognized.

Poor grant accounting can create problems during audits, investor reviews, and future funding rounds.

A proper biotech accounting system should track:

• Grant award amount.
• Eligible costs.
• Restricted funds.
• Deferred revenue.
• Reimbursable expenses.
• Grant reporting deadlines.
• Budget-to-actual spending.

R&D Tax Credits for Biotechnology Firms

R&D tax credits can help biotechnology firms reduce tax liability or offset payroll taxes when eligible.

The IRS provides guidance on the qualified small business payroll tax credit for increasing research activities, which is especially relevant for early-stage companies with research expenses and limited taxable income.

A biotech accounting firm can help identify qualified research expenses and organize supporting documentation for tax advisors.

Common qualified research cost categories may include:

• Wages for technical employees.
• Supplies used in research.
• Contract research expenses.
• Certain prototype or testing costs.
• Research-related cloud or software costs, depending on eligibility.

Biotech companies should not wait until tax season to organize R&D documentation. Monthly tracking creates stronger support.

Burn Rate and Runway Reporting

Burn rate shows how much cash a biotech company spends each month.

Runway shows how long the company can operate before it needs more capital.

These two metrics are critical because biotech firms often operate before product revenue. Investors, boards, and founders need to know how current spending affects the next funding milestone.

A biotech accounting partner should provide:

• Monthly burn rate.
• Net burn and gross burn.
• Cash runway.
• Budget vs. actuals.
• Program-level spending.
• Payroll and headcount costs.
• Forecasted financing needs.

This is where fractional CFO services can support biotech founders who need financial planning without hiring a full-time CFO.

Monthly Close and Investor-Ready Financials

Monthly close is the process of reviewing, reconciling, and finalizing financial records each month.

For biotech firms, monthly close should include bank reconciliation, credit card reconciliation, AP review, payroll review, accruals, prepaid expenses, grant tracking, R&D classification, and financial statement preparation.

Clean monthly financials help biotech companies prepare for:

• Board meetings.
• Investor updates.
• Grant reporting.
• Audits.
• Fundraising.
• Due diligence.
• M&A discussions.
• IPO readiness.

Bay Forward provides accounting and bookkeeping support for biotech, pharmaceutical, and medical technology companies, including audit readiness and compliance support.

Need Biotech Accounting That Tracks More Than Transactions?

Bay Forward helps biotech and life sciences companies manage R&D costs, grants, CRO invoices, clinical trial spending, monthly close, burn rate, and investor-ready reporting.

What Should Biotech Firms Look for in an Accounting Partner?

A biotechnology firm should choose an accounting partner that understands both financial operations and biotech-specific reporting.

Use this checklist before choosing a provider.